Perform Another (Advanced) Search

1.  Study Posting (77) Trial #85426, Vaccines, Bronx, NY
...an experimental CMV vaccine You will not qualify as a recipient if you: • Have an autoimmune disease • Are a poor risk patient • Have a certain type of anemia For more information, Ira ...
View Page

2.  Study Posting (4519) Trial #101664, Rheumatoid Arthritis, Salford, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

3.  Study Posting (4519) Trial #102554, Rheumatoid Arthritis, Norwich, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

4.  Study Posting (4519) Trial #99684, Rheumatoid Arthritis, Maidstone, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

5.  Study Posting (4519) Trial #96693, Rheumatoid Arthritis, London, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

6.  Study Posting (4519) Trial #96680, Rheumatoid Arthritis, Liverpool, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

7.  Study Posting (4519) Trial #97615, Rheumatoid Arthritis, Leeds, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

8.  Study Posting (4519) Trial #103154, Rheumatoid Arthritis, Derby, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

9.  Study Posting (4519) Trial #97587, Rheumatoid Arthritis, Cambridge, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

10.  Study Posting (4519) Trial #99616, Rheumatoid Arthritis, Aberdeen, United Kingdom
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

11.  Study Posting (4519) Trial #98022, Rheumatoid Arthritis, Valencia, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

12.  Study Posting (4519) Trial #104086, Rheumatoid Arthritis, Sevilla, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

13.  Study Posting (4519) Trial #96926, Rheumatoid Arthritis, Madrid, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

14.  Study Posting (4519) Trial #98740, Rheumatoid Arthritis, La Laguna, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

15.  Study Posting (4519) Trial #97944, Rheumatoid Arthritis, Granada, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

16.  Study Posting (4519) Trial #113238, Rheumatoid Arthritis, Cádiz, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

17.  Study Posting (4519) Trial #101507, Rheumatoid Arthritis, Alcorcon, Spain
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

18.  Study Posting (4519) Trial #97893, Rheumatoid Arthritis, Moscow, Russian Federation
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

19.  Study Posting (4519) Trial #98714, Rheumatoid Arthritis, Auckland, New Zealand
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page

20.  Study Posting (4519) Trial #97762, Rheumatoid Arthritis, Amsterdam, Netherlands
...treatment with methotrexate for at least 12 weeks, at a stable dose. Exclusion Criteria: • rheumatic autoimmune disease or inflammatory joint disease, other than RA; • previous treatment with rituximab; • concurrent treatment with any ...
View Page